Company Profile

AstraZeneca plc (NYSE: AZN)
Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 8.31
% Price Change (last 13 weeks): 1.14
% Price Change (last 26 weeks): -4.75
% Price Change (last 52 weeks): 4.68
% Price Change (year to date): 5.12
Management Effectiveness
Return on Equity (%): 10.47
Return on Assets (%): 2.20
Return on Invested Capital (%): 8.26
Gross Profit Margin (%): 72.35
Net Profit Margin (%): 5.47
Operating Profit Margin (%): 11.51
Price & Volume
50-day Moving Average: $52.40
200-day Moving Average: $53.51
Avg. Daily Vol. (last 50 days): 11,686,622
Avg. Daily Vol. (last 200 days): 7,038,490
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca plc
Cambridge Biomedical Campus 1 Francis Crick Avenue
Cambridge CA CB2 0AA

Phone: 44.20.3749.5000
Fax: 44.12.2335.2858
Per Share Data
Earnings (1year) ($): 0.96
Annual Dividend ($): 1.37
Current P/E Ratio (ttm): n/a
Book Value ($): 5.00
Cash Flow ($): 1.58
Valuation Ratios
Price/Earnings (x): 54.50
Price/Sales (x): 5.30
Price/Book (x): 9.97
Price/Cash Flow (x): 41.77
Financial Strength
Quick Ratio (x): 0.68
Current Ratio (x): 0.86
LT Debt/Equity (x): 123.54
Total Debt/Equity (x): 138.85

Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.